A Multicenter, Randomized, Double-blind, Sham-controlled, Comparative Study of SI-6603 in Subjects With Lumbar Disc Herniation (Phase 3)
Phase of Trial: Phase III
Latest Information Update: 25 Nov 2018
At a glance
- Drugs Condoliase (Primary)
- Indications Intervertebral disc displacement
- Focus Therapeutic Use
- Sponsors Seikagaku Corporation
- 24 Jul 2018 Status changed from planning to recruiting.
- 19 Feb 2018 According to a Seikagaku Corporation media release, the will initiate this trial in the second quarter of 2018.
- 06 Dec 2017 New trial record